A citation-based method for searching scientific literature

A J Williams, S C Blacklow, T Collins. Mol Cell Biol 1999
Times Cited: 78







List of co-cited articles
542 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
Alice T Shaw, Todd M Bauer, Filippo de Marinis, Enriqueta Felip, Yasushi Goto, Geoffrey Liu, Julien Mazieres, Dong-Wan Kim, Tony Mok, Anna Polli,[...]. N Engl J Med 2020
305
1

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
Rajen J Mody, Yi-Mi Wu, Robert J Lonigro, Xuhong Cao, Sameek Roychowdhury, Pankaj Vats, Kevin M Frank, John R Prensner, Irfan Asangani, Nallasivam Palanisamy,[...]. JAMA 2015
260
1

Unusual high-grade and low-grade glioma in an infant with PPP1CB-ALK gene fusion.
Andrew Ng, Michael L Levy, Denise M Malicki, John Ross Crawford. BMJ Case Rep 2019
19
5

Intracranial Neoplasms in the First Year of Life: Results of a Third Cohort of Patients From a Single Institution.
Sebastian M Toescu, Gregory James, Kim Phipps, Owase Jeelani, Dominic Thompson, Richard Hayward, Kristian Aquilina. Neurosurgery 2019
11
9

ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.
Jeffrey S Ross, Siraj M Ali, Omotayo Fasan, Jared Block, Sumanta Pal, Julia A Elvin, Alexa B Schrock, James Suh, Sahar Nozad, Sungeun Kim,[...]. Oncologist 2017
63
1

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Regina I Jakacki, Kenneth J Cohen, Allen Buxton, Mark D Krailo, Peter C Burger, Marc K Rosenblum, Daniel J Brat, Ronald L Hamilton, Sandrah P Eckel, Tianni Zhou,[...]. Neuro Oncol 2016
70
1

The role of the ALK receptor in cancer biology.
B Hallberg, R H Palmer. Ann Oncol 2016
174
1



Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.
Linn Fagerberg, Björn M Hallström, Per Oksvold, Caroline Kampf, Dijana Djureinovic, Jacob Odeberg, Masato Habuka, Simin Tahmasebpoor, Angelika Danielsson, Karolina Edlund,[...]. Mol Cell Proteomics 2014
1

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.
Matthew Clarke, Alan Mackay, Britta Ismer, Jessica C Pickles, Ruth G Tatevossian, Scott Newman, Tejus A Bale, Iris Stoler, Elisa Izquierdo, Sara Temelso,[...]. Cancer Discov 2020
92
1

ZNF397, a new class of interphase to early prophase-specific, SCAN-zinc-finger, mammalian centromere protein.
S L Bailey, S C Chang, B Griffiths, A N Graham, R Saffery, E Earle, K H A Choo, P Kalitsis. Chromosoma 2008
4
25

ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties.
Merrida A Childress, Stephen M Himmelberg, Huiqin Chen, Wanleng Deng, Michael A Davies, Christine M Lovly. Mol Cancer Res 2018
56
1

Novel PPP1CB-ALK fusion protein in a high-grade glioma of infancy.
Yasmin Aghajan, Michael L Levy, Denise M Malicki, John Ross Crawford. BMJ Case Rep 2016
26
3

Clinical and molecular characteristics of congenital glioblastoma.
Margaret E Macy, Diane K Birks, Valerie N Barton, Michael H Chan, Andrew M Donson, B K Kleinschmidt-Demasters, Lynne T Bemis, Michael H Handler, Nicholas K Foreman. Neuro Oncol 2012
36
2

Identification of ALK as a major familial neuroblastoma predisposition gene.
Yaël P Mossé, Marci Laudenslager, Luca Longo, Kristina A Cole, Andrew Wood, Edward F Attiyeh, Michael J Laquaglia, Rachel Sennett, Jill E Lynch, Patrizia Perri,[...]. Nature 2008
901
1

Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives.
Giulia Ceglie, Maria Vinci, Andrea Carai, Sabrina Rossi, Giovanna Stefania Colafati, Antonella Cacchione, Assunta Tornesello, Evelina Miele, Franco Locatelli, Angela Mastronuzzi. Diagnostics (Basel) 2020
11
9

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.
Ana S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, Michal Zapotocky, Alvaro Lassaletta, Christopher Li, Taylor Bridge, Byungjin Kim, Anthony Arnoldo, Paul E Kowalski,[...]. Nat Commun 2019
117
1

Lorlatinib in a Child with ALK-Fusion-Positive High-Grade Glioma.
Aditi Bagchi, Brent A Orr, Olivia Campagne, Sandeep Dhanda, Sreenath Nair, Quynh Tran, Anthony M Christensen, Amar Gajjar, Larissa V Furtado, Aksana Vasilyeva,[...]. N Engl J Med 2021
3
33


Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.
P K Duffner, J P Krischer, P C Burger, M E Cohen, J W Backstrom, M E Horowitz, R A Sanford, H S Friedman, L E Kun. J Neurooncol 1996
79
1

Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Tilman T Rau, Eva Bettschen, Carol Büchi, Lucine Christe, Amanda Rohner, Michael D Müller, Joseph W Carlson, Sara Imboden, Inti Zlobec. Mod Pathol 2021
18
5

GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA.
Chenwei Li, Zefang Tang, Wenjie Zhang, Zhaochen Ye, Fenglin Liu. Nucleic Acids Res 2021
96
1

Tumor budding in colorectal carcinoma: time to take notice.
Bojana Mitrovic, David F Schaeffer, Robert H Riddell, Richard Kirsch. Mod Pathol 2012
195
1

CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
Shih-Chieh Chang, Yi-Chun Lai, Yen-Chung Chen, Nai-Kuan Wang, Wei-Shu Wang, Jiun-I Lai. Asia Pac J Clin Oncol 2018
34
2


Molecular mechanisms of epithelial-mesenchymal transition.
Samy Lamouille, Jian Xu, Rik Derynck. Nat Rev Mol Cell Biol 2014
1

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines.
J Jongsma, M H Oomen, M A Noordzij, J C Romijn, T H van Der Kwast, F H Schröder, G J van Steenbrugge. Prostate 2000
95
1

Dynamic EMT: a multi-tool for tumor progression.
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, Marc P Stemmler. EMBO J 2021
87
1

Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab.
Toshifumi Fujiwara, Takanori Eguchi, Chiharu Sogawa, Kisho Ono, Jun Murakami, Soichiro Ibaragi, Jun-Ichi Asaumi, Stuart K Calderwood, Kuniaki Okamoto, Ken-Ichi Kozaki. Oral Oncol 2018
58
1

Heterochromatin protein 1: don't judge the book by its cover!
Florence Hediger, Susan M Gasser. Curr Opin Genet Dev 2006
121
1

TGF-beta-induced epithelial to mesenchymal transition.
Jian Xu, Samy Lamouille, Rik Derynck. Cell Res 2009
1

Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency.
Rupa Sridharan, Michelle Gonzales-Cope, Constantinos Chronis, Giancarlo Bonora, Robin McKee, Chengyang Huang, Sanjeet Patel, David Lopez, Nilamadhab Mishra, Matteo Pellegrini,[...]. Nat Cell Biol 2013
158
1

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.
Angela M Krebs, Julia Mitschke, María Lasierra Losada, Otto Schmalhofer, Melanie Boerries, Hauke Busch, Martin Boettcher, Dimitrios Mougiakakos, Wilfried Reichardt, Peter Bronsert,[...]. Nat Cell Biol 2017
550
1


Triple knockdown of CDC37, HSP90-alpha and HSP90-beta diminishes extracellular vesicles-driven malignancy events and macrophage M2 polarization in oral cancer.
Kisho Ono, Chiharu Sogawa, Hotaka Kawai, Manh Tien Tran, Eman A Taha, Yanyin Lu, May Wathone Oo, Yuka Okusha, Hirohiko Okamura, Soichiro Ibaragi,[...]. J Extracell Vesicles 2020
35
2

MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A.
Dan Wu, Hua Tan, Weijun Su, Dongmei Cheng, Guanwen Wang, Juan Wang, Ding A Ma, George M Dong, Peiqing Sun. Oncogene 2022
4
25

EMT Transition States during Tumor Progression and Metastasis.
Ievgenia Pastushenko, Cédric Blanpain. Trends Cell Biol 2019
1

Transfection, Spinfection, Exofection, and Luciferase Assays for Analysis of CCN Genes Expression Mechanism.
Takanori Eguchi, Yanyin Lu, Eman A Taha, Yuka Okusha. Methods Mol Biol 2023
1
100

TGF-beta and cancer.
Brian Bierie, Harold L Moses. Cytokine Growth Factor Rev 2006
321
1

Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition.
Toshifumi Fujiwara, Takanori Eguchi, Chiharu Sogawa, Kisho Ono, Jun Murakami, Soichiro Ibaragi, Jun-Ichi Asaumi, Kuniaki Okamoto, Stuart K Calderwood, Ken-Ichi Kozaki. Biochem Biophys Res Commun 2018
35
2

Snail-induced claudin-11 prompts collective migration for tumour progression.
Ching-Fei Li, Jia-Yang Chen, Yang-Hui Ho, Wen-Hao Hsu, Liang-Chun Wu, Hsin-Yi Lan, Dennis Shin-Shian Hsu, Shyh-Kuan Tai, Ying-Chih Chang, Muh-Hwa Yang. Nat Cell Biol 2019
78
1



Identification of the tumour transition states occurring during EMT.
Ievgenia Pastushenko, Audrey Brisebarre, Alejandro Sifrim, Marco Fioramonti, Tatiana Revenco, Soufiane Boumahdi, Alexandra Van Keymeulen, Daniel Brown, Virginie Moers, Sophie Lemaire,[...]. Nature 2018
710
1

Knockout of MMP3 Weakens Solid Tumor Organoids and Cancer Extracellular Vesicles.
Eman A Taha, Chiharu Sogawa, Yuka Okusha, Hotaka Kawai, May Wathone Oo, Abdellatif Elseoudi, Yanyin Lu, Hitoshi Nagatsuka, Satoshi Kubota, Ayano Satoh,[...]. Cancers (Basel) 2020
29
3

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Gaoping Chen, Nicholas Shukeir, Anil Potti, Kanishka Sircar, Armen Aprikian, David Goltzman, Shafaat A Rabbani. Cancer 2004
229
1

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.
Xin Ye, Wai Leong Tam, Tsukasa Shibue, Yasemin Kaygusuz, Ferenc Reinhardt, Elinor Ng Eaton, Robert A Weinberg. Nature 2015
480
1

A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus.
Emma C Ferber, Mihoko Kajita, Anthony Wadlow, Lara Tobiansky, Carien Niessen, Hiroyoshi Ariga, Juliet Daniel, Yasuyuki Fujita. J Biol Chem 2008
118
1

Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
Chiharu Sogawa, Takanori Eguchi, Yuri Namba, Yuka Okusha, Eriko Aoyama, Kazumi Ohyama, Kuniaki Okamoto. Cells 2021
8
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.